Low vitamin D levels are linked with increased cardiovascular disease risk in young adults: a sub-study and secondary analyses from the ACTIBATE randomized controlled trial.

What Was Tested

Researchers studied Vitamin D, K2, Magnesium and Zinc in this randomized controlled trial publication.

Vitamin D deficiency is related to metabolic disturbances.

Indeed, a poor vitamin D status has been usually detected in patients with cardiovascular disease (CVD).

However, the relationship between vitamin D and CVD risk factors in young adults remains controversial at present.

Who Took Part

The study group was 177 adults.

PubMed indexes the participants as teenagers, young adults and adults, both men and women.

How the Study Was Run

The design is described as randomized.

Random assignment meant chance, not the researchers, decided who got Vitamin D, K2, Magnesium and Zinc and who got the comparison, which limits bias.

Fasting CVD risk factors (i.e., body composition, blood pressure, glucose metabolism, lipid profile, liver, and inflammatory markers) were determined by routine methods.

A panel of 63 oxylipins and endocannabinoids (eCBs) was also analyzed by targeted metabolomics.

What Was Measured

PubMed files the paper under topics including Cardiovascular Diseases, Cross-Sectional Studies, Vitamin D, Vitamin D Deficiency, Risk Factors, Biomarkers and Heart Disease Risk Factors.

The authors tagged it with the keywords 25-hydroxyvitamin D, Cardiovascular risk, Inflammation, Oxylipins and Young adults.

What This Means in Plain Language

The paper is a randomized study of Vitamin D, K2, Magnesium and Zinc in 177 adults.

The abstract goes on to report its results in about 3 sentences; this page does not restate them, so read the paper for the findings and their limits.

The publication is from 2024 (Journal of endocrinological investigation), a journal based in Italy.

More context: the Vitamin D, K2, Magnesium and Zinc compound page, all human trials.